BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT00000822-completion@plaintrial.com
DTSTAMP:20261111T015944Z
DTSTART;VALUE=DATE:199905
SUMMARY:A Phase I/II Double-Blind Controlled Trial to Determine the Safety 
 and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Inf
 ected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 2
 00-400/mm3 CD4+ T Cells — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT00000822
URL:https://plaintrial.com/trial/NCT00000822
END:VEVENT
END:VCALENDAR